Literature DB >> 2068803

OC-125 as a diagnostic aid in the cytological evaluation of ascitic cells in patients with ovarian carcinoma.

R V Skov1, P Bichel.   

Abstract

OC-125 is a monoclonal antibody raised against tumor cells from a patient with serous cystadenocarcinoma and reacting with an antigen CA-125 on the surface of ovarian epithelial cancer cells. We investigated whether immunohistochemical determination of CA-125 in cell samples from the peritoneal cavity could be used to discriminate between non-specific inflammatory changes in the mesothelium and malignant ovarian tumour cells. Three categories of patients were investigated: patients with disseminated serous or endometrioid ovarian carcinomas, patients with non-specific inflammatory changes in the peritoneal cavity and patients subjected to simple hysterectomy with no pathological changes in the mesothelium. In all cases of ovarian cancer CA-125 positive cells could be detected in the peritoneal fluid; none of the other categories showed positive reaction for CA-125. The results suggest that OC-125 may be a valuable adjunct in differentiating neoplastic from other cells in ascitic fluid from patients with some types of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068803     DOI: 10.1007/BF01600153

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  4 in total

1.  Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors.

Authors:  G J Fleuren; M Nap; J G Aalders; J B Trimbos; H W de Bruijn
Journal:  Cancer       Date:  1987-11-15       Impact factor: 6.860

2.  Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.

Authors:  E J Nouwen; P G Hendrix; S Dauwe; M W Eerdekens; M E De Broe
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

3.  Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125.

Authors:  S E Kabawat; R C Bast; A K Bhan; W R Welch; R C Knapp; R B Colvin
Journal:  Int J Gynecol Pathol       Date:  1983       Impact factor: 2.762

4.  Reactivity of a monoclonal antibody with human ovarian carcinoma.

Authors:  R C Bast; M Feeney; H Lazarus; L M Nadler; R B Colvin; R C Knapp
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.